Financial Data and Key Metrics Changes - Revenue for Q3 2025 was $153 million, representing a 7% increase year over year, with EPS of $0.33, up 22% year over year, and cash from operations at $29 million, all exceeding the midpoint of the guidance range [4][12][10] - Gross margins for the MedTech and specialty audio segment were 53%, flat compared to the previous year, while Precision Devices segment gross margins improved to 41.5%, up 150 basis points year over year [12][13] Business Line Data and Key Metrics Changes - MedTech and specialty audio revenue was $65 million, up 2% year over year, driven by increased demand in the specialty audio market [12][5] - Precision Devices segment revenue was $88 million, up 12% year over year, with growth across all end markets including MedTech, defense, industrial, and EV and energy [5][13] Market Data and Key Metrics Changes - The defense market showed particularly strong growth, with design wins outpacing other end markets, driven by increased defense spending and demand for electronic warfare solutions [6][7] - Channel inventories are now at normalized levels, matching orders to end market demand, indicating a healthy market environment [8] Company Strategy and Development Direction - The company is focused on leveraging unique technologies to design custom-engineered solutions and deliver them at scale, positioning itself well for growth in 2025 and beyond [10][11] - The strategy includes expanding specialty film production and pursuing synergistic acquisitions while maintaining a strong balance sheet [10][16] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in organic growth rates at the high end of the stated range of 4% to 6% for the total company, supported by strong secular growth trends and a healthy backlog of orders [9][10] - The company anticipates strong revenue and EPS growth in the second half of 2025, driven by new design wins and increased order activity [9][18] Other Important Information - The company purchased $20 million in shares and reduced outstanding bank borrowings by $15 million, maintaining a strong balance sheet with cash of $93 million and $176 million in debt [10][15] - The company expects to generate operating cash flow of 16% to 20% of revenues for the full year 2025 [15] Q&A Session Summary Question: Update on specialty film capacity and demand outlook - Management indicated that the specialty film line is expected to generate $55 to $60 million in revenue next year, with a backlog of $25 to $30 million [20][22] Question: Design activity and growth expectations for segments - Management expects MedTech and specialty audio growth in the range of 2% to 4%, while Precision Devices may exceed the high end of the 6% to 8% growth range due to strong design win activity [24][25] Question: M&A environment and focus - The company remains focused on acquisitions but is being selective, ensuring any acquisition makes strategic sense [35][36] Question: Impact of palladium prices on gross margins - Management noted that current palladium prices are not expected to negatively impact gross margins due to pre-buys and monitoring of market conditions [40][41] Question: Specialty film gross margin improvements - Management anticipates sequential improvement in specialty film gross margins, with significant improvements expected by mid to late Q2 2026 as production ramps up [46][47]